Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

1.6K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

1.6K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
1.6K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.9K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.9K
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

1.5K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.5K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.0K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.0K
Asthma-I: Introduction01:29

Asthma-I: Introduction

3.2K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the drivers of satisfaction and retention of an advanced practice workforce.

Journal of the American Association of Nurse Practitioners·2026
Same author

The integration of a collaborative testing modality in graduate nurse practitioner education.

Journal of the American Association of Nurse Practitioners·2026
Same author

A guide to the creation of a professional advancement program for advanced practice registered nurses and physician associates.

Journal of the American Association of Nurse Practitioners·2026
Same author

The implementation and impact of an advanced practice recognition program.

Journal of the American Association of Nurse Practitioners·2023
Same author

Effect of Benralizumab in Patients With Severe Eosinophilic Asthma and Chronic Rhinosinusitis With Nasal Polyps: A Case Series.

American journal of rhinology & allergy·2020

Related Experiment Video

Updated: Dec 10, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.3K

New developments in asthma therapeutics.

Jessica Freyer Most1, Stephanie Bork1

  • 1Jane & Leonard Korman Respiratory Institute, Jefferson Health/National Jewish Health, 834 Walnut Street, Suite 650, Philadelphia, PA 19107, United States.

Current Opinion in Pharmacology
|August 29, 2020
PubMed
Summary

Asthma research has identified new drug targets for chronic airway inflammation. Novel therapies show promise for severe asthma, potentially benefiting more patients with further upstream targeting.

More Related Videos

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

41.2K
A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

4.6K

Related Experiment Videos

Last Updated: Dec 10, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.3K
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

41.2K
A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

4.6K

Area of Science:

  • Pulmonology
  • Immunology
  • Pharmacology

Background:

  • Asthma is a complex respiratory disease defined by chronic airway inflammation.
  • Advances in understanding asthma have driven the development of targeted therapies and biomarkers.
  • A significant portion of asthma patients remain refractory to standard inhaled treatments.

Purpose of the Study:

  • To review the evolution of asthma pharmacologic targets.
  • To highlight the impact of biomarkers on personalized asthma management.
  • To discuss the potential of novel upstream therapeutic targets for broader asthma patient populations.

Main Methods:

  • Literature review of recent advancements in asthma research.
  • Analysis of current pharmacologic targets and biomarkers.
  • Evaluation of emerging therapies for severe and refractory asthma.

Main Results:

  • Personalized medicine approaches have improved asthma management.
  • Targeting specific cytokines has shown efficacy in a subset of severe asthmatics.
  • Current treatments still leave a considerable percentage of patients with poor symptom control.

Conclusions:

  • Targeting upstream inflammatory pathways may offer broader therapeutic benefits.
  • Continued research into novel asthma targets is crucial for improving patient outcomes.
  • Personalized approaches, informed by biomarkers, are transforming severe asthma care.